2019
DOI: 10.1007/s11419-019-00503-z
|View full text |Cite
|
Sign up to set email alerts
|

In vivo and in vitro metabolism of the novel synthetic cannabinoid 5F-APINAC

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…The novel SC 5F-APINAC represents a recently emerged NPS belonging to an adamantylindazole structural class [ 7 ]. The in vitro and in vivo metabolism of 5F-APINAC in rats has been described postulating the rapid hydrolysis and hydroxylation of the parent drug with a consequent formation of its main metabolites—5F-pentylidazol carboxylic acid and hydroxyl derivatives [ 7 ]. Notably, due to the rapid metabolism of 5F-APINAC, the parent drug has not been detected so far in urine.…”
Section: Introductionmentioning
confidence: 99%
“…The novel SC 5F-APINAC represents a recently emerged NPS belonging to an adamantylindazole structural class [ 7 ]. The in vitro and in vivo metabolism of 5F-APINAC in rats has been described postulating the rapid hydrolysis and hydroxylation of the parent drug with a consequent formation of its main metabolites—5F-pentylidazol carboxylic acid and hydroxyl derivatives [ 7 ]. Notably, due to the rapid metabolism of 5F-APINAC, the parent drug has not been detected so far in urine.…”
Section: Introductionmentioning
confidence: 99%
“…Inevitably, it is necessary to consider the ethical bottleneck to conduct studies in humans without a clear understanding of the drug´s toxicology. In this way, alternative models have been used to circumvent the use of human volunteers in metabolism studies [10][11][12]. Among them, zebrafish (Danio rerio) has already demonstrated advantages over in vitro and classical animal models [13][14][15].…”
Section: Introductionmentioning
confidence: 99%